For inpatients in the 2021-22 season, pharmacy will be providing the following vaccines:
FluLaval quadrivalent 0.5 mL syringe which is approved for patients greater than 6 months of age. The 0.5 mL dose is approved for both adult and pediatric populations. This is an expansion of the age indication for FluLaval Quadrivalent previously licensed for ≥3 years, to ≥6 months. There will be no 0.25 mL syringes/doses required for our pediatric population.
Fluzone HD quadrivalent 0.5mL syringe which is approved for patients 65 years of age or older
FluLaval Quadrivalent must be stored under refrigeration. See manufacturer storage guidelines for recommendations outside of refrigeration temperatures (above 8°C [46°F]).
Inpatient Influenza Vaccine Screening: See Policy 900.4011
Storage, Monitoring and Handing of Refrigerated or Frozen Medications and Vaccines: See Policy 916.3910
Therapeutic Interchange for High Dose to Standard Dose flu vaccine: See Protocol 900.6000
Current VIS: CDC Vaccine Information Sheet (Inactivated Influenza)
Immunization schedules and more information: See Vaccination Information
For inpatients in the 2021-22 season, pharmacy will be providing the following vaccines:
FluLaval Quadrivalent must be stored under refrigeration. See manufacturer storage guidelines for recommendations outside of refrigeration temperatures (above 8°C [46°F]).